VERY-LOW-DOSE CYTARABINE FOR MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOID-LEUKEMIA IN THE ELDERLY

被引:0
|
作者
WORSLEY, A
MUFTI, GJ
COPPLESTONE, JA
OSCIER, DG
HAMBLIN, TJ
机构
来源
LANCET | 1986年 / 1卷 / 8487期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:966 / 966
页数:1
相关论文
共 50 条
  • [31] ACUTE MYELOID-LEUKEMIA IN ELDERLY PATIENTS
    GIUSTOLISI, R
    DIRAIMONDO, F
    GUGLIELMO, P
    CACCIOLA, RR
    PAFUMI, M
    HAEMATOLOGICA, 1984, 69 (02) : 240 - 242
  • [32] ACUTE MYELOID-LEUKEMIA IN ELDERLY ADULTS
    TUCKER, J
    THOMAS, AE
    GREGORY, WM
    GANESAN, TS
    MALIK, STA
    AMESS, JAL
    LIM, J
    WILLIS, L
    ROHATINER, AZS
    LISTER, TA
    HEMATOLOGICAL ONCOLOGY, 1990, 8 (01) : 13 - 21
  • [33] CALCITONIN GENE HYPERMETHYLATION IN CHRONIC MYELOID-LEUKEMIA AND IN MYELODYSPLASTIC SYNDROMES
    PALOTIE, A
    IHALAINEN, J
    MALINEN, T
    PAKKALA, S
    RUUTU, T
    JANSSON, SE
    AMERICAN JOURNAL OF HUMAN GENETICS, 1991, 49 (04) : 123 - 123
  • [34] Myelodysplastic syndromes and acute myeloid leukemias in the elderly
    Mueller, Beatrice U.
    Seipel, Katja
    Pabst, Thomas
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2018, 58 : 28 - 32
  • [35] LOW-DOSE CYTARABINE - COMPLETE REMISSION IN A PATIENT WITH ACUTE MYELOID-LEUKEMIA IN RELAPSE SUGGESTING A DIFFERENTIATION EFFECT
    ABBADESSA, A
    BRUZZESE, L
    ARCIDIACONE, G
    ACTA HAEMATOLOGICA, 1987, 78 : 211 - 212
  • [36] Vorinostat in acute myeloid leukemia and myelodysplastic syndromes
    Prebet, Thomas
    Vey, Norbert
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2011, 20 (02) : 287 - 295
  • [37] EXTRAMEDULLARY LEUKEMIA (EML) IN MYELODYSPLASTIC SYNDROMES (MDS) - NOT A TRUE INDICATION OF IMPENDING ACUTE MYELOID-LEUKEMIA (AML)
    EDENFIELD, WJ
    BYRD, JC
    AYLESWORTH, C
    DOW, NS
    DAWSON, N
    BLOOD, 1994, 84 (10) : A631 - A631
  • [38] Efficacy and toxicity of low-dose melphalan in myelodysplastic syndromes and acute myeloid leukemia with multilineage dysplasia
    Robak, T
    Szmigielska-Kaplon, A
    Urbanska-Rys, H
    Chojnowski, K
    Wrzesien-Kus, A
    NEOPLASMA, 2003, 50 (03) : 172 - 175
  • [39] Phase Ib study of the mTOR inhibitor everolimus with low dose cytarabine in elderly acute myeloid leukemia
    Tiong, Ing Soo
    Tan, Peter
    McManus, Julie
    Cummings, Nik
    Sadawarte, Sonali
    Catalano, John
    Hills, Robert
    Wei, Andrew
    LEUKEMIA & LYMPHOMA, 2018, 59 (02) : 493 - 496
  • [40] Cytarabine Dose for Acute Myeloid Leukemia REPLY
    Lowenberg, Bob
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (22): : 2168 - 2169